Skip to main content

Central nervous system prophylaxis in haematological malignancies

Buy Article:

$51.00 plus tax (Refund Policy)



Given the poor prognosis of central nervous system (CNS) involvement in haematological malignancies, management is directed towards prevention. CNS prophylaxis may take the form of intrathecal therapy, cranial irradiation, systemic therapy or some combinĀ­ation of these. The toxicity of these methods is an important consideration. A risk-orientated approach to the delivery of CNS prophylaxis in each disorder is required. (Intern Med J 2002; 32: 252−258)

Keywords: central nervous system; cranial irradiation; high-dose methotrexate; leukaemia; lymphoma; prophylaxis

Document Type: Research Article


Affiliations: Mater Hospital, Brisbane, Queensland, Australia

Publication date: 2002-05-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more